Amebiasis Treatment Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2022 to 2028

The Amebiasis Treatment Market is expected to witness market growth at a rate of 4% in the forecast period of 2022 to 2028. 

Amebiasis is an intestinal infection caused by the Entamoeba Histolytica parasite. Symptoms of the disease include loose stools, abdominal cramps, and abdominal pain. Amebiasis is common in areas with less developed sanitation facilities, such as Asia Pacific, Central America, parts of South America and Africa. Amoebosis is mainly transmitted through food or water contaminated with Entamoeba Histolytica. Amebiasis can cause diarrhea (with or without blood) in both adults and children, leading to high morbidity and mortality. The organism, Entamoeba Histolytica, can damage organs and may require surgical intervention in cases of perforation of the colon and other tissues. However, amoebosis can be treated with some antibiotics, anthelmintics, and antiprotozoal drugs, such as metronidazole, paromomycin, and tinidazole. Diagnosis of the disease is usually made by microscopic identification of microorganisms in stool samples.


Market Segments

By Drug Type-

  • Metronidazole
  • Paromomycin
  • Tinidazole
  • Iodoquinol
  • Dehydroemetine
  • Chloroquine phosphate
  • Others

By Distribution Channel-

  • Hospitals
  • Online Pharmacies
  • Retail Pharmacies

Key Players

Major Players Are: Pfizer Inc., Impax Laboratories, Lupin Pharmaceuticals, Inc., Sanofi, Actelion Pharmaceuticals Ltd., Glenmark Pharmaceuticals, Sun Pharmaceutical Industries Inc., Heritage Pharmaceuticals Inc., Mission Pharmacal Co., Novel Laboratories 


Scope of the Report

The research study analyzes the global Amebiasis Treatment industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Amebiasis Treatment Market Report

1. What was the Amebiasis Treatment Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2022-2028).

2. What will be the CAGR of Amebiasis Treatment Market during the forecast period (2022-2028)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
4. Which manufacturer/vendor/players in the Amebiasis Treatment Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.

The report will be delivered within 48-72 hours after payment confirmation